DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Questions
Schema
External Links
Analytics And Tracking
Libraries
Hosting Providers

We began analyzing https://link.springer.com/article/10.1007/s00380-018-1136-2, but it redirected us to https://link.springer.com/article/10.1007/s00380-018-1136-2. The analysis below is for the second page.

Title[redir]:
Comparison of the effects of linagliptin and voglibose on endothelial function in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, pilot study (EFFORT) | Heart and Vessels
Description:
Endothelial dysfunction contributes to poor cardiovascular prognosis in patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD). The effect of dipeptidyl peptidase-4 inhibitors on endothelial function remains controversial. We sought to compare the effects of linagliptin and voglibose on endothelial function, as assessed by reactive hyperemia-peripheral arterial tonometry (RH-PAT). Sixteen patients with newly diagnosed T2DM and CAD were randomized 1:1 to linagliptin (5 mg, once-daily) or voglibose (0.9 mg, thrice-daily). The RH-PAT and laboratory parameters, including 75 g oral glucose tolerance test, were measured at baseline and 3 months. Linagliptin increased serum levels of active glucagon-like peptide-1 and high-molecular-weight adiponectin. Age-, sex-, and baseline-adjusted changes in logarithmic RH-PAT index (LnRHI) after 3 months were significant between groups (linagliptin, 0.135 ± 0.097; voglibose, − 0.124 ± 0.091; P = 0.047). In the linagliptin group, change in LnRHI was positively correlated with change in high-density lipoprotein cholesterol and negatively correlated with changes in both urine albumin-to-creatinine ratio and high-sensitivity C-reactive protein. Furthermore, linagliptin treatment for 3 months reduced serum levels of both glucose and insulin at 2 h, relative to voglibose, in the age-, sex-, and baseline-adjusted model. Linagliptin improved endothelial function relative to voglibose, accompanied by amelioration of glycemic, renal, and cardiometabolic parameters, in patients with newly diagnosed T2DM and CAD. Trial registration Unique Trial Number, UMIN 000029169 ( https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012442 ).

Matching Content Categories {📚}

Education
Health & Fitness
Social Networks

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't see how the site brings in money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Doi.org could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

pubmed, article, endothelial, google, scholar, cas, function, diabetes, linagliptin, patients, type, central, heart, artery, voglibose, coronary, disease, study, dysfunction, vascular, research, tanaka, cardiovasc, japan, privacy, cookies, content, randomized, node, dipeptidyl, peptidase, related, inhibitor, publish, search, vessels, effects, manuscript, inoue, cardiovascular, effect, glucose, access, lerman, diabetol, saga, mitsubishi, tanabe, boehringer, ingelheim,

Topics {✒️}

jp/cgi-open-bin/ctr_e/ctr_view high-sensitivity c-reactive protein month download article/chapter jun-ichi oyama high-density lipoprotein cholesterol high-molecular-weight adiponectin logarithmic rh-pat index full article pdf coronary artery disease dipeptidyl peptidase-4 inhibitors koichi node privacy choices/manage cookies masashi sakuma & teruo inoue research program faculty endothelial vasomotor function dipeptidyl peptidase-4 inhibitor author information authors article koyama improves endothelial dysfunction unique pharmacological profile dipeptidyl-peptidase 4 inhibition ameliorates endothelial dysfunction early endothelial dysfunction boston scientific japan diabetes mellitus serum adiponectin level vascular endothelial functions european economic area short communication published flow-mediated vasodilatation stabilises arteriosclerotic lesions flow-mediated vasodilation excellent secretarial assistance ethics declarations conflict placebo-controlled study conditions privacy policy newly diagnosed t2dm poor cardiovascular prognosis prologue study investigators article log glucose-independent improvement article heart accepting optional cookies check access fukuoka wajiro hospital instant access dokkyo medical university endothelial function baseline-adjusted model anti-inflammatory effects

Questions {❓}

Ceriello A (2005) Postprandial hyperglycemia and diabetes complications: is it time to treat?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Comparison of the effects of linagliptin and voglibose on endothelial function in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, pilot study (EFFORT)
         description:Endothelial dysfunction contributes to poor cardiovascular prognosis in patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD). The effect of dipeptidyl peptidase-4 inhibitors on endothelial function remains controversial. We sought to compare the effects of linagliptin and voglibose on endothelial function, as assessed by reactive hyperemia-peripheral arterial tonometry (RH-PAT). Sixteen patients with newly diagnosed T2DM and CAD were randomized 1:1 to linagliptin (5 mg, once-daily) or voglibose (0.9 mg, thrice-daily). The RH-PAT and laboratory parameters, including 75 g oral glucose tolerance test, were measured at baseline and 3 months. Linagliptin increased serum levels of active glucagon-like peptide-1 and high-molecular-weight adiponectin. Age-, sex-, and baseline-adjusted changes in logarithmic RH-PAT index (LnRHI) after 3 months were significant between groups (linagliptin, 0.135 ± 0.097; voglibose, − 0.124 ± 0.091; P = 0.047). In the linagliptin group, change in LnRHI was positively correlated with change in high-density lipoprotein cholesterol and negatively correlated with changes in both urine albumin-to-creatinine ratio and high-sensitivity C-reactive protein. Furthermore, linagliptin treatment for 3 months reduced serum levels of both glucose and insulin at 2 h, relative to voglibose, in the age-, sex-, and baseline-adjusted model. Linagliptin improved endothelial function relative to voglibose, accompanied by amelioration of glycemic, renal, and cardiometabolic parameters, in patients with newly diagnosed T2DM and CAD. Trial registration Unique Trial Number, UMIN 000029169 ( https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012442 ).
         datePublished:2018-02-09T00:00:00Z
         dateModified:2018-02-09T00:00:00Z
         pageStart:958
         pageEnd:964
         sameAs:https://doi.org/10.1007/s00380-018-1136-2
         keywords:
            Endothelial function
            Linagliptin
            Voglibose
            Type 2 diabetes mellitus
            Coronary artery disease
            Cardiology
            Cardiac Surgery
            Vascular Surgery
            Biomedical Engineering and Bioengineering
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00380-018-1136-2/MediaObjects/380_2018_1136_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00380-018-1136-2/MediaObjects/380_2018_1136_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00380-018-1136-2/MediaObjects/380_2018_1136_Fig3_HTML.gif
         isPartOf:
            name:Heart and Vessels
            issn:
               1615-2573
               0910-8327
            volumeNumber:33
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Japan
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Taku Koyama
               affiliation:
                     name:Fukuoka Wajiro Hospital
                     address:
                        name:Department of Cardiology, Fukuoka Wajiro Hospital, Fukuoka, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Atsushi Tanaka
               affiliation:
                     name:Saga University
                     address:
                        name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Hisako Yoshida
               affiliation:
                     name:Saga University
                     address:
                        name:Clinical Research Center, Saga University, Saga, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jun-ichi Oyama
               affiliation:
                     name:Saga University
                     address:
                        name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shigeru Toyoda
               affiliation:
                     name:Dokkyo Medical University
                     address:
                        name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Masashi Sakuma
               affiliation:
                     name:Dokkyo Medical University
                     address:
                        name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Teruo Inoue
               affiliation:
                     name:Dokkyo Medical University
                     address:
                        name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yoritaka Otsuka
               affiliation:
                     name:Fukuoka Wajiro Hospital
                     address:
                        name:Department of Cardiology, Fukuoka Wajiro Hospital, Fukuoka, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Koichi Node
               affiliation:
                     name:Saga University
                     address:
                        name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Comparison of the effects of linagliptin and voglibose on endothelial function in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, pilot study (EFFORT)
      description:Endothelial dysfunction contributes to poor cardiovascular prognosis in patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD). The effect of dipeptidyl peptidase-4 inhibitors on endothelial function remains controversial. We sought to compare the effects of linagliptin and voglibose on endothelial function, as assessed by reactive hyperemia-peripheral arterial tonometry (RH-PAT). Sixteen patients with newly diagnosed T2DM and CAD were randomized 1:1 to linagliptin (5 mg, once-daily) or voglibose (0.9 mg, thrice-daily). The RH-PAT and laboratory parameters, including 75 g oral glucose tolerance test, were measured at baseline and 3 months. Linagliptin increased serum levels of active glucagon-like peptide-1 and high-molecular-weight adiponectin. Age-, sex-, and baseline-adjusted changes in logarithmic RH-PAT index (LnRHI) after 3 months were significant between groups (linagliptin, 0.135 ± 0.097; voglibose, − 0.124 ± 0.091; P = 0.047). In the linagliptin group, change in LnRHI was positively correlated with change in high-density lipoprotein cholesterol and negatively correlated with changes in both urine albumin-to-creatinine ratio and high-sensitivity C-reactive protein. Furthermore, linagliptin treatment for 3 months reduced serum levels of both glucose and insulin at 2 h, relative to voglibose, in the age-, sex-, and baseline-adjusted model. Linagliptin improved endothelial function relative to voglibose, accompanied by amelioration of glycemic, renal, and cardiometabolic parameters, in patients with newly diagnosed T2DM and CAD. Trial registration Unique Trial Number, UMIN 000029169 ( https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012442 ).
      datePublished:2018-02-09T00:00:00Z
      dateModified:2018-02-09T00:00:00Z
      pageStart:958
      pageEnd:964
      sameAs:https://doi.org/10.1007/s00380-018-1136-2
      keywords:
         Endothelial function
         Linagliptin
         Voglibose
         Type 2 diabetes mellitus
         Coronary artery disease
         Cardiology
         Cardiac Surgery
         Vascular Surgery
         Biomedical Engineering and Bioengineering
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00380-018-1136-2/MediaObjects/380_2018_1136_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00380-018-1136-2/MediaObjects/380_2018_1136_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00380-018-1136-2/MediaObjects/380_2018_1136_Fig3_HTML.gif
      isPartOf:
         name:Heart and Vessels
         issn:
            1615-2573
            0910-8327
         volumeNumber:33
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Japan
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Taku Koyama
            affiliation:
                  name:Fukuoka Wajiro Hospital
                  address:
                     name:Department of Cardiology, Fukuoka Wajiro Hospital, Fukuoka, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Atsushi Tanaka
            affiliation:
                  name:Saga University
                  address:
                     name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Hisako Yoshida
            affiliation:
                  name:Saga University
                  address:
                     name:Clinical Research Center, Saga University, Saga, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jun-ichi Oyama
            affiliation:
                  name:Saga University
                  address:
                     name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shigeru Toyoda
            affiliation:
                  name:Dokkyo Medical University
                  address:
                     name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Masashi Sakuma
            affiliation:
                  name:Dokkyo Medical University
                  address:
                     name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Teruo Inoue
            affiliation:
                  name:Dokkyo Medical University
                  address:
                     name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yoritaka Otsuka
            affiliation:
                  name:Fukuoka Wajiro Hospital
                  address:
                     name:Department of Cardiology, Fukuoka Wajiro Hospital, Fukuoka, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Koichi Node
            affiliation:
                  name:Saga University
                  address:
                     name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Heart and Vessels
      issn:
         1615-2573
         0910-8327
      volumeNumber:33
Organization:
      name:Springer Japan
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Fukuoka Wajiro Hospital
      address:
         name:Department of Cardiology, Fukuoka Wajiro Hospital, Fukuoka, Japan
         type:PostalAddress
      name:Saga University
      address:
         name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
         type:PostalAddress
      name:Saga University
      address:
         name:Clinical Research Center, Saga University, Saga, Japan
         type:PostalAddress
      name:Saga University
      address:
         name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
         type:PostalAddress
      name:Dokkyo Medical University
      address:
         name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
         type:PostalAddress
      name:Dokkyo Medical University
      address:
         name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
         type:PostalAddress
      name:Dokkyo Medical University
      address:
         name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
         type:PostalAddress
      name:Fukuoka Wajiro Hospital
      address:
         name:Department of Cardiology, Fukuoka Wajiro Hospital, Fukuoka, Japan
         type:PostalAddress
      name:Saga University
      address:
         name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Taku Koyama
      affiliation:
            name:Fukuoka Wajiro Hospital
            address:
               name:Department of Cardiology, Fukuoka Wajiro Hospital, Fukuoka, Japan
               type:PostalAddress
            type:Organization
      name:Atsushi Tanaka
      affiliation:
            name:Saga University
            address:
               name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Hisako Yoshida
      affiliation:
            name:Saga University
            address:
               name:Clinical Research Center, Saga University, Saga, Japan
               type:PostalAddress
            type:Organization
      name:Jun-ichi Oyama
      affiliation:
            name:Saga University
            address:
               name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
               type:PostalAddress
            type:Organization
      name:Shigeru Toyoda
      affiliation:
            name:Dokkyo Medical University
            address:
               name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
               type:PostalAddress
            type:Organization
      name:Masashi Sakuma
      affiliation:
            name:Dokkyo Medical University
            address:
               name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
               type:PostalAddress
            type:Organization
      name:Teruo Inoue
      affiliation:
            name:Dokkyo Medical University
            address:
               name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
               type:PostalAddress
            type:Organization
      name:Yoritaka Otsuka
      affiliation:
            name:Fukuoka Wajiro Hospital
            address:
               name:Department of Cardiology, Fukuoka Wajiro Hospital, Fukuoka, Japan
               type:PostalAddress
            type:Organization
      name:Koichi Node
      affiliation:
            name:Saga University
            address:
               name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Cardiology, Fukuoka Wajiro Hospital, Fukuoka, Japan
      name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
      name:Clinical Research Center, Saga University, Saga, Japan
      name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
      name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
      name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
      name:Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan
      name:Department of Cardiology, Fukuoka Wajiro Hospital, Fukuoka, Japan
      name:Department of Cardiovascular Medicine, Saga University, Saga, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(182)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

4.19s.